MedPath

Outcome in Hemodialysis of Promus stent

Phase 4
Conditions
Ischemic heart disease Chronic renal failure on hemodialysis
Registration Number
JPRN-UMIN000006684
Lead Sponsor
Coronary Intervention Trial and Evaluation group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

CPA Cardiogenic shock Emergent PCI STEMI Intolerance with antiplatelet therapy Planned PCI for other lesions in 6 months Restenosis after DES Severe valvular heart disease Critical limb ischemia CTO No indication for PCI

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Target Vessel Failure including cardiac death, myocardial infarction in the target vessel and target vessel revascularization at 12 months
Secondary Outcome Measures
NameTimeMethod
Binary restenosis rate by QCA Late lumen loss by QCA Death, TLR, MACE at 12 months Stent thrombosis rate Neointimal volume by IVUS osteoprotegerin and MACE rate Dialyzer and MACE rate or late lumen loss
© Copyright 2025. All Rights Reserved by MedPath